Impact of artificial intelligence on future clinical pharmacy research and scholarship
Authors:
- Alexandre ChanACAlexandre Chan
- William L. BakerWBWilliam L. Baker
- Daniel AbaziaDADaniel Abazia
- Jerry BaumanJBJerry Bauman
- C. Lindsay DeVaneCDC. Lindsay DeVane
- Kellie J. GoodletKGKellie J. Goodlet
- Natalie HallNHNatalie Hall
- James Kevin HicksJames Kevin Hicks
- Ellen JonesEJEllen Jones
- Chi‐Hua LuCLChi‐Hua Lu
- Donald C. MooreDMDonald C. Moore
- Nicholas R. NelsonNicholas R. Nelson
Open Access
- 13 February 2025
- journal article
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (4) , 311-316
Abstract
Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role of AI in clinical pharmacy research and scholarship. The potential benefits/opportunities together with the limitations/challenges of AI are reviewed for stages of the scientific method including (1) developing the research question(s), study design, and execution; (2) data analysis; and (3) reporting and dissemination of clinical pharmacy research. Benefits and opportunities of AI in clinical pharmacy research include streamlining hypothesis generation and facilitating study design, overcoming limitations of traditional statistical analysis techniques, facilitating manuscript development and dissemination, and expediting peer review. Limitations and challenges of AI include the introduction of biases in subject recruitment; generation of false information, also known as “AI hallucinations”; concern of “black box” analyses that are difficult to validate; potential legal liabilities; lack of accountability; and the need for investigators to ensure the accuracy and integrity of AI‐generated content. In summary, rapid progress of AI capabilities has great potential to revolutionize and accelerate clinical pharmacy research and scholarship; however, it is also imperative to recognize and mitigate the challenges and limitations introduced by AI.Keywords
This publication has 43 references indexed in Scilit:
- Reporting Use of AI in Research and Scholarly Publication—JAMA Network GuidanceJAMA, 2024
- Large Language Model Advanced Data Analysis Abuse to Create a Fake Data Set in Medical ResearchJAMA Ophthalmology, 2023
- Evaluation and Comparison of Ophthalmic Scientific Abstracts and References by Current Artificial Intelligence ChatbotsJAMA Ophthalmology, 2023
- Artificial intelligence to support publishing and peer review: A summary and reviewLearned Publishing, 2023
- Using ChatGPT and other AI‐assisted tools to improve manuscripts readability and languageInternational Journal of Imaging Systems and Technology, 2023
- A comparison of ChatGPT-generated articles with human-written articlesSkeletal Radiology, 2023
- Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Machine learning to predict vasopressin responsiveness in patients with septic shockPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Machine Learning: Algorithms, Real-World Applications and Research DirectionsSN Computer Science, 2021
- Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A reviewContemporary Clinical Trials Communications, 2018